- Exchange: Xetra
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Fresenius SE & Co KGaA
+ Add to WatchlistFRE:GR
95.711 EUR 0.166 0.17%As of 13:22:56 ET on 05/23/2013.
Snapshot for Fresenius SE & Co KGaA (FRE)
| Open: | 94.470 | Day's Range: | 94.300 - 96.400 | Volume: | 342,351 |
|---|---|---|---|---|---|
| Previous Close: | 95.877 | 52wk Range: | 73.000 - 99.910 | 1-Yr Rtn: | +27.68% |
Key Statistics for FRE
| Current P/E Ratio (ttm) | 18.1960 |
|---|---|
| Estimated P/E(12/2013) | 16.3749 |
| Relative P/E vs. DAX | 1.1402 |
| Earnings Per Share (EUR) (ttm) | 5.2600 |
| Est. EPS (EUR) (12/2013) | 5.8450 |
| Est. PEG Ratio | 1.2654 |
| Market Cap (M EUR) | 17,062.51 |
| Shares Outstanding (M) | 178.27 |
| 30 Day Average Volume | 407,770 |
| Price/Book (mrq) | 2.1489 |
| Price/Sale (ttm) | 0.8422 |
| Dividend Indicated Gross Yield | 1.15% |
| Cash Dividend (EUR) | 1.1000 |
| Last Dividend | 05/20/2013 |
| 5 Year Dividend Growth | 10.76% |
| Next Earnings Announcement | 07/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for FRE
Company Profile & Key Executives for FRE
Fresenius SE & Co KGaA i s a global health care group with products and services for dialysis, the hospital and the medical care of patients at home. The Company sells dialysis, infusion, transfusion, and diagnostics equipment and systems, blood separators and plasma and hemofilters, nutritional liquids, and solid and liquid pharmaceuticals.
| Ulf Mark SchneiderChairman-Mgmt Board | Stephan SturmCFO/Member-Mgmt Board |
| Juergen GoetzChief Legal & Compliance Ofcr | Francesco De MeoMember-Mgmt Board |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
FRE News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page